{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:31:53Z","timestamp":1794663113847,"version":"4.9.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jvoice.2025.03.023","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T18:17:25Z","timestamp":1743617845000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Laryngeal Symptoms in Anti-IgLON5 Disease: Case Reports and a Systematic Review of Airway Management and Recommendations"],"prefix":"10.1016","author":[{"given":"D.","family":"Alayadhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Voisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Coulombeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"P\u00e9rouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"C\u00e9ruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Philouze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2025.03.023_bib1","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurologi-cal accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jvoice.2025.03.023_bib2","first-page":"575","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet\u00a0Neurol"},{"key":"10.1016\/j.jvoice.2025.03.023_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jvoice.2025.03.023_bib4","article-title":"Isolated dysphagia as initial sign of anti-IgLON5 syndrome","volume":"4","author":"Schr\u00f6der","year":"2016","journal-title":"Neurol\u00a0(R) Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.jvoice.2025.03.023_bib5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/cns.13038","article-title":"Motor neuron disease-like phenotype associated with anti-IgLON5 disease","volume":"24","author":"Tao","year":"2018","journal-title":"CNS Neurosci\u00a0Ther"},{"key":"10.1016\/j.jvoice.2025.03.023_bib6","first-page":"1056","article-title":"Anti-IgLON5 disease: a case with 11-year clinical course and review of the literature","volume":"10","author":"Nissen","year":"2019","journal-title":"Front\u00a0Neurol"},{"key":"10.1016\/j.jvoice.2025.03.023_bib7","article-title":"Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy","volume":"6","author":"Brunetti","year":"2019","journal-title":"Neurol (R) Neuroimmunol\u00a0Neuroinflammation"},{"key":"10.1016\/j.jvoice.2025.03.023_bib8","doi-asserted-by":"crossref","first-page":"E724","DOI":"10.1002\/lary.28911","article-title":"A novel presentation of the acute airway: anti-IgLON5 disease","volume":"131","author":"Chen","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2025.03.023_bib9","article-title":"Anti-IgLON5 disease: a new bulbar-onset motor neuron mimic syndrome","volume":"8","author":"Werner","year":"2021","journal-title":"Neurol\u00a0(R) Neuroimmunol\u00a0Neuroinflammation"},{"key":"10.1016\/j.jvoice.2025.03.023_bib10","article-title":"Delayed benefit from aggressive immunotherapy in waxing and waning anti-IgLON5 disease","volume":"8","author":"Shambrook","year":"2021","journal-title":"Neurol\u00a0(R) Neuroimmunol\u00a0Neuroinflammation"},{"key":"10.1016\/j.jvoice.2025.03.023_bib11","first-page":"683","article-title":"Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature","volume":"79","author":"Tagliapietra","year":"2021","journal-title":"J\u00a0Alzheimer's Dis\u00a0JAD"},{"key":"10.1016\/j.jvoice.2025.03.023_bib12","first-page":"849","article-title":"Neuroimaging findings in a patient with anti-IgLON5 disease: cerebrospinal fluid dynamics abnormalities","volume":"12","author":"Urso","year":"2022","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"10.1016\/j.jvoice.2025.03.023_bib13","article-title":"Thinking beyond otorhinolaryngology in patients presenting with bilateral vocal cord paresis","volume":"2023","author":"Usman","year":"2023","journal-title":"J\u00a0Surg\u00a0Case Rep"},{"key":"10.1016\/j.jvoice.2025.03.023_bib14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.otorri.2024.04.001","article-title":"Upper airway manifestations of anti-IgLON5 disease: otorhinolaryngological point of view","volume":"75","author":"Pastene","year":"2024","journal-title":"Acta Otorrinolaringol Espanola"},{"key":"10.1016\/j.jvoice.2025.03.023_bib15","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.1016\/j.amjmed.2024.08.008","article-title":"Anti-IgLON5 disease presenting with esophageal achalasia and hypercapnic respiratory failure","volume":"137","author":"Yeo","year":"2024","journal-title":"Am J Med"},{"key":"10.1016\/j.jvoice.2025.03.023_bib16","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2169\/internalmedicine.2865-23","article-title":"Anti-IgLON5 disease showing an improvement in dysautonomia, including vocal cord palsy, via combined immunotherapy","volume":"63","author":"Sato","year":"2024","journal-title":"Int Med (Tokyo, Japan)"},{"key":"10.1016\/j.jvoice.2025.03.023_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106992","article-title":"Anti-IgLON5 disease as a differential diagnosis of multiple system atrophy","volume":"124","author":"Ono","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jvoice.2025.03.023_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36451","article-title":"Anti-IgLON5 disease with severe central sleep apnea-hypopnea syndrome: a case report","volume":"10","author":"Qin","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jvoice.2025.03.023_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/WCO.0000000000000677","article-title":"Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease","volume":"32","author":"Gaig","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jvoice.2025.03.023_bib20","doi-asserted-by":"crossref","first-page":"e1367","DOI":"10.1212\/WNL.0000000000012639","article-title":"Frequency and characterization of movement disorders in anti-IgLON5 disease","volume":"97","author":"Gaig","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jvoice.2025.03.023_bib21","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00415-023-12145-8","article-title":"Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review","volume":"271","author":"McWilliam","year":"2024","journal-title":"J Neurol"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199725001171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199725001171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:48:08Z","timestamp":1777578488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199725001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":21,"alternative-id":["S0892199725001171"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2025.03.023","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laryngeal Symptoms in Anti-IgLON5 Disease: Case Reports and a Systematic Review of Airway Management and Recommendations","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2025.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Voice Foundation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}